ING Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,868
| Closed | -$992K | – | 547 |
|
|
2024
Q1 | $992K | Sell |
2,868
-3,598
| -56% | -$1.24M | 0.01% | 514 |
|
|
2023
Q4 | $2.09M | Buy |
6,466
+6,344
| +5,200% | +$2.05M | 0.02% | 400 |
|
|
2023
Q3 | $43.7K | Buy |
+122
| New | +$43.7K | ﹤0.01% | 552 |
|
|
2023
Q2 | – | Sell |
-3,659
| Closed | -$1.75M | – | 552 |
|
|
2023
Q1 | $1.75M | Sell |
3,659
-2
| -0.1% | -$958 | 0.02% | 379 |
|
|
2022
Q4 | $1.54M | Buy |
+3,661
| New | +$1.54M | 0.02% | 387 |
|
|
2022
Q3 | – | Sell |
-1,873
| Closed | -$927K | – | 418 |
|
|
2022
Q2 | $927K | Sell |
1,873
-1,555
| -45% | -$770K | 0.01% | 459 |
|
|
2022
Q1 | $1.93M | Sell |
3,428
-4,092
| -54% | -$2.31M | 0.02% | 400 |
|
|
2021
Q4 | $5.68M | Buy |
7,520
+1,016
| +16% | +$768K | 0.05% | 253 |
|
|
2021
Q3 | $4.85M | Buy |
6,504
+4,734
| +267% | +$3.53M | 0.06% | 200 |
|
|
2021
Q2 | $1.14M | Buy |
1,770
+343
| +24% | +$221K | 0.02% | 425 |
|
|
2021
Q1 | $815K | Sell |
1,427
-1
| -0.1% | -$571 | 0.02% | 426 |
|
|
2020
Q4 | $832K | Buy |
1,428
+955
| +202% | +$556K | 0.02% | 435 |
|
|
2020
Q3 | $244K | Buy |
+473
| New | +$244K | 0.01% | 444 |
|
|
2018
Q4 | – | Sell |
-3,063
| Closed | -$959K | – | 707 |
|
|
2018
Q3 | $959K | Sell |
3,063
-39
| -1% | -$12.2K | 0.02% | 372 |
|
|
2018
Q2 | $895K | Buy |
+3,102
| New | +$895K | 0.02% | 341 |
|
|
2018
Q1 | – | Sell |
-2,310
| Closed | -$551K | – | 736 |
|
|
2017
Q4 | $551K | Buy |
2,310
+587
| +34% | +$140K | 0.01% | 477 |
|
|
2017
Q3 | $383K | Sell |
1,723
-809
| -32% | -$180K | 0.01% | 601 |
|
|
2017
Q2 | $573K | Buy |
+2,532
| New | +$573K | 0.01% | 442 |
|